Amygdala Neurosciences
Pre-clinicalAddiction is a treatable recurring chronic disease. Amygdala Neurosciences is a biopharmaceutical company whose mission is to invent and develop first-in-class medicines to treat substance use disorders (SUD). Learn More Leading the discovery and development of ALDH2 inhibitors for substance use disorders. Science of Addiction Helping patients escape cravings due to addiction Addiction is compulsive […]
About
Addiction is a treatable recurring chronic disease. Amygdala Neurosciences is a biopharmaceutical company whose mission is to invent and develop first-in-class medicines to treat substance use disorders (SUD). Learn More Leading the discovery and development of ALDH2 inhibitors for substance use disorders. Science of Addiction Helping patients escape cravings due to addiction Addiction is compulsive […]
Funding History
1Total raised: $5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile